Home > Journals > Journal of Plastic Surgery and Transplantation

Journal of Plastic Surgery and Transplantation

Submit your article Read this Journals View all journals
Full Text (PDF)
Review Article

Guidelines for Management of Cutaneous Squamous Cell Carcinoma

Ravi Kumar Chittoria, Jacob Antony Chakiath

Author Information

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator. 

Journal of Plastic Surgery and Transplantation 3(1):p 27-34, January–June 2023. | DOI: NA

How Cite This Article:

Chakiath JA, Chittoria RK. Guidelines for Management of Cutaneous Squamous Cell Carcinoma. J Plast Surg Transplant. 2023;3(1):27-34.

Timeline

Received : January 25, 2023         Accepted : February 26, 2023          Published : June 15, 2023

Abstract

Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer. This review article gives an overview of cSSC in terms of etiology, pathophysiology, epidemiology, prognosis, clinical presentation, work up, treatment and highlights various guidelines like American College of Radiology, Scottish Intercollegiate Guidelines Network's, Dermatological Cooperative Oncology Group of the German Cancer Society, British Association of Dermatologists Guidelines for the management of cSSC

References

  • 1.   Howell JY, Ramsey ML. Cancer, Squamous Cell, Skin. 2017 Jun.
  • 2.   Brash DE. Roles of the transcription factor p53 in keratinocyte carcinomas. Br J Dermatol. 2006 May. 154 Suppl 1:8-10.
  • 3.   Rogers HW, Weinstock MA, Feldman SR, Coldiron BM. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012. JAMA Dermatol. 2015 Oct. 151 (10):1081-6.
  • 4.   Staples MP, Elwood M, Burton RC, Williams JL, Marks R, Giles GG. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust. 2006 Jan 2. 184(1):6-10.
  • 5.   McCall CO, Chen SC. Squamous cell carcinoma of the legs in African Americans. J Am AcadDermatol. 2002 Oct. 47(4):524-9.
  • 6.   Housman TS, Feldman SR, Williford PM, et al. Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am AcadDermatol. 2003 Mar. 48(3):425-9.
  • 7.   Edge SB, Byrd DR, Compton CC, eds. Cutaneous squamous cell carcinoma and other cutaneous carcinomas. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2009. 301-9.
  • 8.   Clayman GL, Lee JJ, Holsinger FC, et al. Mortality risk from squamous cell skin cancer. J ClinOncol. 2005 Feb 1. 23(4):759-65.
  • 9.   Eigentler TK, Leiter U, Hafner HM, Garbe C, Rocken M, Breuninger H. Survival of patients with cutaneous squamous cell carcinoma Results of a prospective cohort study. J Invest Dermatol. 2017 Jul 20.
  • 10.   Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am AcadDermatol. 1992 Jun. 26(6):976-90.
  • 11.   Ross AS, Whalen FM, Elenitsas R, Xu X, Troxel AB, Schmults CD. Diameter of involved nerves predicts outcomes in cutaneous squamous cell carcinoma with perineural invasion: an investigator-blinded retrospective cohort study. Dermatol Surg. 2009 Dec. 35(12):1859-66.
  • 12.   Vasan K, Low TH, Gupta R, et al. Lymph node ratio as a prognostic factor in metastatic cutaneous head and neck squamous cell carcinoma. Head Neck. 2018 Jan 23.
  • 13.   Salasche SJ. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am AcadDermatol. 2000 Jan. 42(1 Pt 2):4-7.
  • 14.   Goepfert H, Dichtel WJ, Medina JE, Lindberg RD, Luna MD. Perineural invasion in squamous cell skin carcinoma of the head and neck. Am J Surg. 1984 Oct. 148(4):542-7.
  • 15.   Hasmat S, Mooney C, Gao K, et al. Regional Metastasis in Head and Neck Cutaneous Squamous Cell Carcinoma: An Update on the Significance of Extra-Nodal Extension and Soft Tissue Metastasis. Ann SurgOncol. 2020 Aug. 27 (8):2840-5.
  • 16.   Baart VM, van Duijn C, van Egmond SL, et al. EGFR and αvβ6 as Promising Targets for Molecular Imaging of Cutaneous and Mucosal Squamous Cell Carcinoma of the Head and Neck Region. Cancers (Basel). 2020 Jun 5. 12 (6).
  • 17.   Fukushima S, Masuguchi S, Igata T, et al. Evaluation of sentinel node biopsy for cutaneous squamous cell carcinoma. J Dermatol. 2014 Jun. 41 (6):539-41.
  • 18.   Saito Y, Fujikawa H, Takatsuka S, Abe R, Takenouchi T. Risk factors for lymph node metastasis in cutaneous squamous cell carcinoma: a long-term retrospective study of Japanese patients. Int J ClinOncol. 2021 Mar. 26 (3):606-12.
  • 19.   Ahmed MM, Moore BA, Schmalbach CE. Utility of head and neck cutaneous squamous cell carcinoma sentinel node biopsy: a systematic review. Otolaryngol Head Neck Surg. 2014 Feb. 150 (2):180 7.
  • 20.   Bander TS, Nehal KS, Lee EH. Cutaneous Squamous Cell Carcinoma: Updates in Staging and Management. DermatolClin. 2019 Jul. 37 (3):241-51.
  • 21.   Stratigos AJ, Garbe C, Dessinioti C, et al. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention. Eur J Cancer. 2020 Mar. 128:60-82.
  • 22.   Nelson BR, Railan D, Cohen S. Mohs' micrographic surgery for nonmelanoma skin cancers. ClinPlast Surg. 1997 Oct. 24(4):705-18.
  • 23.   Veness MJ, Morgan GJ, Palme CE, Gebski V. Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice. Laryngoscope. 2005 May. 115(5):870-5.
  • 24.   Rudkin AK, Muecke JS. Adjuvant 5-fluorouracil in the treatment of localised ocular surface squamous neoplasia. Br J Ophthalmol. 2011 Jul. 95(7):947-50.
  • 25.   Suen JK, Bressler L, Shord SS, Warso M, Villano JL. Cutaneous squamous cell carcinoma responding serially to single-agent cetuximab. Anticancer Drugs. 2007 Aug. 18(7):827-9.
  • 26.   Arnold AW, Bruckner-Tuderman L, Zuger C, Itin PH. Cetuximab therapy of metastasizing cutaneous squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa. Dermatology. 2009. 219(1):80-3.
  • 27.   Reeves TD, Hill EG, Armeson KE, Gillespie MB. Cetuximab therapy for head and neck squamous cell carcinoma: a systematic review of the data. Otolaryngol Head Neck Surg. 2011 May. 144(5):676 84.
  • 28.   Baggi A, Quaglino P, Rubatto M, et al. Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma. Eur J Cancer. 2021 Sep 15. 157:250-8.
  • 29.   Migden MR, Rischin D, Schmults CD, et al. PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma. N Engl J Med. 2018 Jul 26. 379 (4):341-351.
  • 30.   Keytruda (pembrolizumab) [package insert]. Whitehouse Station, NJ: Merck & Co, Inc. June 2020.
  • 31.   Koyfman SA, Cooper JS, Beitler JJ, et al. Aggressive nonmelanomatous skin cancer of the head and neck. American College of Radiology. Available at https://acsearch.acr.org/docs/3091669/ Narrative/. 2014; Accessed: Oct 11, 2017.
  • 32.   Scottish Intercollegiate Guidelines Network. Management of primary cutaneous squamous cell carcinoma. A national clinical guideline. SIGN. Available at http://www.sign.ac.uk/sign-140 management-of-primary-cutaneous-squamous cell-carcinoma.html Jun 2014; Accessed: Oct 11, 2017.
  • 33.   Leiter U, Heppt MV, Steeb T, et al. S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma (cSCC) - short version, part 2: epidemiology, surgical and systemic treatment of cSCC, follow-up, prevention and occupational disease. J DtschDermatolGes. 2020 Apr. 18 (4):400 13.
  • 34.   Keohane SG, Botting J, Budny PG, et al. British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020. Br J Dermatol. 2021 Mar. 184 (3):401-14.

Data Sharing Statement

There are no additional data available. All raw data and code are available upon request.

Funding

This research received no funding.

Author Contributions

All authors contributed significantly to the work and approve its publication.

Ethics Declaration

This article does not involve any human or animal subjects, and therefore does not require ethics approval.

Conflicts of Interest

No conflicts of interest in this work

About this article

Cite this article

Chakiath JA, Chittoria RK. Guidelines for Management of Cutaneous Squamous Cell Carcinoma. J Plast Surg Transplant. 2023;3(1):27-34.

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator. 

Received Accepted Published
January 25, 2023 February 26, 2023 June 15, 2023
DOI: NA

Keywords


Article Level Metrics

Last Updated

Monday 22 June 2026, 00:08:15 (IST)

446

Accesses

1
467
00

Citations


NA
NA
NA

Download citation


Article Keywords

Keyword Highlighting

Highlight selected keywords in the article text.


Timeline

Received January 25, 2023
Accepted February 26, 2023
Published June 15, 2023

licence

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator. 


Access this article

Reprint Order Form
Buy this Article
Institutional Subscriptions

Share